Year: 2026

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) — Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s (SEA) next generation e-commerce ecosystem, today announced the pricing of its best efforts public offering of an aggregate of 5,381,819 shares of its common stock (or common stock equivalents in lieu thereof) at a public offering price of $0.55 per share (or per common stock equivalent in lieu thereof), for aggregate gross proceeds of approximately $3.0 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The offering is expected to close on February 13, 2026, subject to satisfaction of customary closing conditions. Rodman & Renshaw LLC is acting as the exclusive placement agent for the offering. The Company intends to use the net proceeds from the offering...

Not for distribution to U.S. newswire services or dissemination in the United States Vancouver, British Columbia, Feb. 11, 2026 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce that it has increased the size of its previously announced non-brokered private placement to $20 million (the “Offering”). Pursuant to the amended terms, the Offering will now consist of 40 million units (the “Units”) at a price of $0.50 per Unit for gross proceeds of $20 million. All other terms of the Offering remain unchanged. Leif Nilsson, Chief Executive Officer, commented: “We appreciate the continued support from existing shareholders and the participation of new long-term investors. The decision to increase the size of the financing reflects constructive demand and...

WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the pricing of an underwritten offering of pre-funded warrants to purchase 74,780,300 shares of common stock at a price to investors of $0.5349 per pre-funded warrant (the “pre-funded warrants”). Each pre-funded warrant is exercisable for one share of common stock at an exercise price of $0.0001 per share. The pre-funded warrants will be exercisable immediately and will be exercisable until all of the pre-funded warrants are exercised in full. The offering is expected to close on or about February 13, 2026, subject to satisfaction of customary closing conditions. All of the pre-funded warrants are...

SANTA CLARA, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that it has reached a settlement agreement with the U.S. Department of Commerce, Bureau of Industry and Security (BIS). The settlement resolves BIS’s allegations that certain customer shipments to China between Nov. 2020 and July 2022 did not comply with the U.S. Export Administration Regulations, based on the company’s misunderstanding of the applicability of those regulations. Under the terms of the settlement, Applied has agreed to pay $252.5 million to the Department of Commerce. In addition, the U.S. Department of Justice and the U.S. Securities and Exchange Commission (SEC) have notified Applied that they have closed their related investigations without action. Applied Materials is pleased that the Department of Justice and SEC have...

DALLAS, Feb. 11, 2026 (GLOBE NEWSWIRE) — Spring Valley Acquisition Corp. IV (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced the closing of its initial public offering of 23,000,000 units at a price of $10.00 per unit on February 11, 2026, which includes the exercise in full by the underwriters of their overallotment option to purchase an additional 3,000,000 units. Total gross proceeds from the offering were $230 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The units began trading on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “SVIVU” on February 10, 2026. Each unit consists...

RICHMOND, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“ARKO”) and ARKO Petroleum Corp., a subsidiary of ARKO (“APC”), today announced the pricing of APC’s initial public offering (the “IPO”) of 11,111,111 shares of its Class A common stock at a price to the public at $18.00 per share (the “IPO Price”). In addition, APC has granted the underwriters a 30-day option to purchase up to an additional 1,666,666 shares of APC’s Class A common stock to cover over-allotments, if any, at the IPO Price, less underwriting discounts and commissions. APC’s Class A common stock has been approved for listing on the Nasdaq Capital Market (“Nasdaq”) under the symbol “APC” and is expected to begin trading on February 12, 2026. The IPO is expected to close on February 13, 2026, subject to customary closing conditions. Upon the...

Hong Kong, Feb. 11, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: AXG) (“AXG” or the “Company”), a leading financial technology firm bridging traditional and digital assets, today announced that it has entered into a securities purchase agreement with Streeterville Capital, LLC (“Streeterville”) for up to US$100 million in financing. Under the agreement, the Company will issue and sell to Streeterville one or more pre-paid purchases with an aggregate purchase price of up to US$100 million for the purchase of AXG’s class A ordinary shares. The initial pre-paid purchase of approximately US$5.415 million (before deducting an original issue discount and transaction expenses) has been completed. Additional pre-paid purchases may be made upon mutual consent of the parties. The proceeds are expected to be used primarily to support...

RADNOR, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on February 9, 2026, the Compensation Committee of Mineralys’ Board of Directors granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of Mineralys common stock to two new non-executive employees. The awards were granted under Mineralys’ 2025 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Mineralys. The options will vest over a four-year...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA Allied’s base shelf prospectus, and the shelf prospectus supplement for the public offering, will be accessible, within two business days, through SEDAR+ TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (TSX:AP.UN) (“Allied”) announced today that it has priced and upsized its previously announced marketed public offering (the “Offering”) and concurrent private placement (the “Private Placement”). The Offering now comprises an aggregate of 40,000,000 units of Allied (the “Units”) at a price of $10.00 per Unit (the “Offering Price”) for aggregate gross proceeds of $400,000,000, representing an increase from the initial offering size of approximately $350,000,000. In connection with the Private...